A not-for-profit community journal that reviews the most important advances in the clinical management of HIV and access to treatment.
Tribute to Bob Munk: long-time HIV positive US treatment activist and educator
Our coverage from IAS 2015 is dedicated to a friend and long time colleague...
Four reasons IAS 2015 will be a milestone HIV conference: a personal view
Why the combined treatment, prevention and programme results at IAS 2015 should change HIV care in the UK and globally...
Starting HIV treatment at high CD4 counts protects against both AIDS and non-AIDS events: overall and in subgroup analyses of START study
Headline study - with additional results at IAS 2015 and NEJM paper that on-one predicted...
New directions in the 2015 WHO ART guidelines
In inprecidented move, top-line WHO recommendation were released at IAS 2015 months ahead of schedule...
Rapid implementation of the 2013 WHO ART guidelines
Important review of implementation success since 2013...
HTB supplement: 2015 Pipeline Report
Activist review of latest research into HIV, HCV and TB: drugs for adults and children, dose optimisation, diagnostics, prevention, cure and vaccines...
Editor: Simon Collins. Contributing editor: Polly Clayden. ISSN 1472-4863.
Subscriptions are free — by post, email and online.
Each issue of HTB is circulated for comments to our medical review board.
- New WHO guidelines for when to start ART and use of PrEP (September 2015) 30 September 2015.
- New UK treatment guidelines for HIV positive adults (2015) 29 September 2015.
- FDA approve additional weight band dosing for children using atazanavir powder 28 September 2015.
- New START study music video: “Now I know” 1 September 2015.
- IAS 2015: the PrEP experience 1 September 2015.
- “We will win or lose the fight against AIDS in next five years”: UNAIDS and Lancet commission report 1 August 2015.
- July/Aug 2015: Volume 16 Number 7/8 1 August 2015.
- 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19 – 22 July 2015, Vancouver, Canada 1 August 2015.
- Tribute to Bob Munk: long-time HIV positive US treatment activist and educator 1 August 2015.
- Four reasons IAS 2015 will be a milestone HIV conference: a personal view 1 August 2015.
- Starting HIV treatment at high CD4 counts protects against both AIDS and non-AIDS events: overall and in subgroup analyses of START study 1 August 2015.
- The option for same day antiretroviral therapy on diagnosis: the future model for HIV care 1 August 2015.
- Pipeline ARVs at IAS 2015: doravirine, BMS-955176 and BMS-663068 1 August 2015.
- New directions in the 2015 WHO ART guidelines 1 August 2015.
- Rapid implementation of the 2013 WHO ART guidelines 1 August 2015.
- Large variation across countries in meeting UNAIDS 90-90-90 targets 1 August 2015.
- Low dose boosted atazanavir is non-inferior to standard dose in Thai treatment optimisation study: LASA 1 August 2015.
- HPTN 052: no HIV transmissions on effective ART but only limited data on viral failure and drug resistance 1 August 2015.
- Dispersible tablet formulation of dolutegravir is bioequivalent to the granule formulation 1 August 2015.
- New case of remission in a perinatally infected teenager 1 August 2015.